N-[5-METHYL-1-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-1H-IMIDAZO-[4,5-B]-PYRIDIN-6-YL]-ACETAMIDE
Compound with spectra: 1 NMR
![N-[5-METHYL-1-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-1H-IMIDAZO-[4,5-B]-PYRIDIN-6-YL]-ACETAMIDE](/api/compound/Hs4oVDZs1sW.png?ph=true&h=300&w=458 "N-[5-METHYL-1-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-1H-IMIDAZO-[4,5-B]-PYRIDIN-6-YL]-ACETAMIDE")
| SpectraBase Compound ID | Hs4oVDZs1sW |
|---|---|
| InChI | InChI=1S/C20H24N4O8/c1-9-14(23-10(2)25)6-15-19(22-9)21-8-24(15)20-18(31-13(5)28)17(30-12(4)27)16(32-20)7-29-11(3)26/h6,8,16-18,20H,7H2,1-5H3,(H,23,25)/t16-,17-,18-,20-/m1/s1 |
| InChIKey | ABYCTYRASQOPTE-SOAMZJECSA-N |
| Mol Weight | 448.43 g/mol |
| Molecular Formula | C20H24N4O8 |
| Exact Mass | 448.159414 g/mol |
| Enantiomer InChIKey | ABYCTYRASQOPTE-JPLJXNOCSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
5-METHYL-6-NITRO-1-(2,3,5-TRI-O-ACETYL-ALPHA-D-RIBOFURANOSYL)-1H-IMIDAZO-[4,5-B]-PYRIDINE
5-METHYL-6-NITRO-1-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-1H-IMIDAZO-[4,5-B]-PYRIDINE
5-METHYL-6-NITRO-3-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-3H-IMIDAZO-[4,5-B]-PYRIDINE
4,6-DIMETHOXY-9-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-3-DEAZA-PURINE
6-CHLORO-2-METHOXY-9-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-3-DEAZA-PURINE
[6-(15)-NH2]-2',3',5'-TRI-O-ACETYL-N-(6)-BENZOYLADENOSINE
5-METHYL-3-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-3H-IMIDAZO-[4,5-B]-PYRIDIN-6-AMINE
9-(2,3,5-tri-O-acetyl-.beta.-D-ribofuranosyl)-N6-(p-toluenesulfonyl)adenine
(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(6-(benzylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate
Adenosine, 2-amino-N,N-dimethyl-, 2',3',5'-triacetate
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of New Nebularine Analogues and Their Inhibitory Activity against Adenosine Deaminase | CHEMICAL & PHARMACEUTICAL BULLETIN | 2015 |